Practical considerations in the use of regorafenib in metastatic colorectal cancer

Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC) has improved considerably, leading to increased overall survival and more patients eligible for third- or later-line therapy. Currently, two oral therapies are recommended in the third-line treatment of mCRC, reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Loupakis, Fotios, Antonuzzo, Lorenzo, Bachet, Jean-Baptiste, Kuan, Feng-Che, Macarulla, Teresa, Pietrantonio, Filippo, Xu, Rui-Hua, Taniguchi, Hiroya, Winder, Thomas, Yuki, Satoshi, Zeng, Shan, Bekaii-Saab, Tanios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607787/
https://www.ncbi.nlm.nih.gov/pubmed/33193826
http://dx.doi.org/10.1177/1758835920956862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607787/
https://www.ncbi.nlm.nih.gov/pubmed/33193826
http://dx.doi.org/10.1177/1758835920956862

Ejemplares similares